Vitamin D supplementation for prevention of cancer in adults (Q24193850)

2

0 references

Dimitrinka Nikolova

3

0 references

Jørn Wetterslev

6

0 references

Goran Bjelakovic

1

0 references

author name string

Kate Whitfield

4

0 references

Goran Krstic

Cochrane Database of Systematic Reviews

5

0 references

language of work or name

English

0 references

publication date

23 June 2014

0 references

published in

0 references

issue

6

0 references

page(s)

CD007469

0 references

cites work

Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Prevention of low-trauma fractures in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and fractures: quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium plus vitamin D supplementation and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium/vitamin D supplementation and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The women's health initiative: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Long-term effects of calcium-vitamin-D3-fortified milk on bone geometry and strength in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium- and vitamin D3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The effects of calcitriol on falls and fractures and physical performance tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D status in a rural postmenopausal female population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcitriol treatment is not effective in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Trials and tribulations of recruiting 2,000 older women onto a clinical trial investigating falls and fractures: Vital D study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Annual high-dose vitamin D3 and mental well-being: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Association between plasma 25-hydroxyvitamin D and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D, UV, and skin cancer in the elderly: to expose or not to expose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Differences in vitamin D3 dosing regimens in a geriatric community-dwelling population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The effect of various vitamin D supplementation regimens in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Prevention of colorectal cancer with vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D2 is much less effective than vitamin D3 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D status and ill health: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 3. Rating the quality of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Nonclassic actions of vitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and cancer: the promise not yet fulfilled

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D supplementation for prevention of mortality in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

SPIRIT 2013 statement: defining standard protocol items for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The anti-cancer actions of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Estimates of optimal vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

IOF position statement: vitamin D recommendations for older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and cancer: a review of molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Prospective study of serum vitamin D and cancer mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Do sunlight and vitamin D reduce the likelihood of colon cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The role of vitamin D in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and prevention of breast cancer: pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Enough is enough: Stop wasting money on vitamin and mineral supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 2. Framing the question and deciding on important outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 5. Rating the quality of evidence--publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines 6. Rating the quality of evidence—imprecision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 7. Rating the quality of evidence--inconsistency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 8. Rating the quality of evidence--indirectness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 9. Rating up the quality of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Modulation of the immune system by UV radiation: more than just the effects of vitamin D?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D: some perspective please

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D(3) is more potent than vitamin D(2) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

A systematic review of vitamin D status in populations worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Extreme between-study homogeneity in meta-analyses could offer useful insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Re: "circulating 25-hydroxyvitamin d and risk of pancreatic cancer".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D in foods and as supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The case of the misleading funnel plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Bioavailability of vitamin D(2) and D(3) in healthy volunteers, a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Which circulating level of 25-hydroxyvitamin D is appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Worldwide status of vitamin D nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Industry sponsorship and research outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D discovery outpaces FDA decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Analysis and reporting of factorial trials: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Minireview: vitamin D receptor: new assignments for an already busy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D compounds for people with chronic kidney disease requiring dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Calcium affects on vascular endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and cancer mortality: systematic review of prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Overcoming the limitations of current meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The association of vitamin D supplementation with the risk of cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D: more than a "bone-a-fide" hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The Vitamin D and Cancer Conundrum: Aiming at a Moving Target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Worldwide vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Estimating required information size by quantifying diversity in random-effects model meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and cancer: clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D in preventive medicine: are we ignoring the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Putting cardiovascular disease and vitamin D insufficiency into perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D and disease prevention with special reference to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Vitamin D supplementation for prevention of cancer in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The women's health initiative calcium–vitamin D trial: overview and baseline characteristics of participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

One year B and D vitamins supplementation improves metabolic bone markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

The "Sunshine Vitamin": Benefits Beyond Bone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effect of Cholecalciferol Supplementation During Winter Months in Patients With Hypertension: A Randomized, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Prevention of low-trauma fractures in older people

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Prevention of low-trauma fractures in older people

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Dietary vitamin D and decreases in cancer rates: Canada as the national experiment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

The skeletal benefits of calcium- and vitamin D3-fortified milk are sustained in older men after withdrawal of supplementation: an 18-mo follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Artifact in the control group undermines the conclusions of a vitamin D and cancer study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Calcium supplementation and cancer incidence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Negative Women's Health Initiative findings stir consternation, debate among researchers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Vitamin D and autoimmune rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Treatment of hypovitaminosis D with pharmacologic doses of cholecalciferol, oralvsintramuscular; an open labeled RCT

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Uncertain verdict as vitamin D goes on trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

Vitamin D supplementation in the age of lost innocence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007469.PUB2

7 January 2021

10.1002/14651858.CD007469.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24953955

1 reference

Consolidated OpenCitations Corpus – April 2017